These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25143247)

  • 21. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
    Marquardt JU; Galle PR; Teufel A
    J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation-promoting culture of competent and noncompetent keratinocytes identifies biomarkers for head and neck cancer.
    Ceder R; Haig Y; Merne M; Hansson A; Zheng X; Roberg K; Nees M; Iljin K; Bloor BK; Morgan PR; Fadeel B; Grafström RC
    Am J Pathol; 2012 Feb; 180(2):457-72. PubMed ID: 22142811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualized targeted therapy for glioblastoma: fact or fiction?
    Weller M; Stupp R; Hegi M; Wick W
    Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant epigenetic modifications in radiation-resistant head and neck cancers.
    Lin HY; Huang TH; Chan MW
    Methods Mol Biol; 2015; 1238():321-32. PubMed ID: 25421668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Getting personal: Head and neck cancer management in the era of genomic medicine.
    Birkeland AC; Uhlmann WR; Brenner JC; Shuman AG
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2250-8. PubMed ID: 25995036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.
    Van Waes C; Musbahi O
    Laryngoscope Investig Otolaryngol; 2017 Oct; 2(5):310-319. PubMed ID: 29094075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomically personalized therapy in head and neck cancer.
    Aung KL; Siu LL
    Cancers Head Neck; 2016; 1():2. PubMed ID: 31093332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health psychology and translational genomic research: bringing innovation to cancer-related behavioral interventions.
    McBride CM; Birmingham WC; Kinney AY
    Am Psychol; 2015; 70(2):91-104. PubMed ID: 25730717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissection of gastric cancer heterogeneity for precision oncology.
    Ho SWT; Tan P
    Cancer Sci; 2019 Nov; 110(11):3405-3414. PubMed ID: 31495054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Big Data in Head and Neck Cancer.
    Resteghini C; Trama A; Borgonovi E; Hosni H; Corrao G; Orlandi E; Calareso G; De Cecco L; Piazza C; Mainardi L; Licitra L
    Curr Treat Options Oncol; 2018 Oct; 19(12):62. PubMed ID: 30361937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.